Carole Cummins1, Andrew Bentley2, Daniel F McAuley3,4, James J McNamee3,4, Hannah Patrick5, Nicholas A Barrett6. 1. Institute of Applied Health Research, University of Birmingham, UK. 2. 2Acute Intensive Care Unit, University Hospital of South Manchester NHS Foundation Trust, UK. 3. 3Wellcome Wolfson Institute for Experimental Medicine, Queen's University Belfast, UK. 4. Regional Intensive Care Unit, Belfast Health and Social Care Trust, UK. 5. 5Observational Data Unit, National Institute for Health and Care Excellence, London, UK. 6. 6Guy's and St Thomas' Hospital NHS Foundation Trust, London, UK.
Abstract
INTRODUCTION: Extracorporeal membrane carbon dioxide removal may have a role in treatment of patients with hypercapnic respiratory failure and refractory hypoxaemia and/or hypercapnia. METHODS: We report on the use, outcomes and complications in United Kingdom intensive care units reporting patients on the Extracorporal Life Support Organisation register. RESULTS: Of 60 patients, 42 (70%) had primarily hypoxic respiratory failure and 18 (30%) primarily hypercapnic respiratory failure. Use of veno-venous procedures increased compared to arterio-venous procedures. Following extracorporeal membrane carbon dioxide removal, ventilatory and blood gas parameters improved at 24 h. Twenty-seven (45%) of patients died before ICU discharge, while 27 (45%) of patients were discharged alive. The most common complications related to thrombosis or haemorrhage. DISCUSSION: There is limited use of extracorporeal membrane carbon dioxide removal in UK clinical practice and outcomes reflect variability in indications and the technology used. Usage is likely to increase with the availability of new, simpler, technology. Further high quality evidence is needed.
INTRODUCTION: Extracorporeal membrane carbon dioxide removal may have a role in treatment of patients with hypercapnic respiratory failure and refractory hypoxaemia and/or hypercapnia. METHODS: We report on the use, outcomes and complications in United Kingdom intensive care units reporting patients on the Extracorporal Life Support Organisation register. RESULTS: Of 60 patients, 42 (70%) had primarily hypoxic respiratory failure and 18 (30%) primarily hypercapnic respiratory failure. Use of veno-venous procedures increased compared to arterio-venous procedures. Following extracorporeal membrane carbon dioxide removal, ventilatory and blood gas parameters improved at 24 h. Twenty-seven (45%) of patients died before ICU discharge, while 27 (45%) of patients were discharged alive. The most common complications related to thrombosis or haemorrhage. DISCUSSION: There is limited use of extracorporeal membrane carbon dioxide removal in UK clinical practice and outcomes reflect variability in indications and the technology used. Usage is likely to increase with the availability of new, simpler, technology. Further high quality evidence is needed.
Authors: Michael C Sklar; Francois Beloncle; Christina M Katsios; Laurent Brochard; Jan O Friedrich Journal: Intensive Care Med Date: 2015-06-25 Impact factor: 17.440
Authors: L Brochard; J Mancebo; M Wysocki; F Lofaso; G Conti; A Rauss; G Simonneau; S Benito; A Gasparetto; F Lemaire Journal: N Engl J Med Date: 1995-09-28 Impact factor: 91.245
Authors: A H Morris; C J Wallace; R L Menlove; T P Clemmer; J F Orme; L K Weaver; N C Dean; F Thomas; T D East; N L Pace; M R Suchyta; E Beck; M Bombino; D F Sittig; S Böhm; B Hoffmann; H Becks; S Butler; J Pearl; B Rasmusson Journal: Am J Respir Crit Care Med Date: 1994-02 Impact factor: 21.405
Authors: Nausherwan K Burki; Raj Kumar Mani; Felix J F Herth; Werner Schmidt; Helmut Teschler; Frank Bonin; Heinrich Becker; Winfried J Randerath; Sven Stieglitz; Lars Hagmeyer; Christina Priegnitz; Michael Pfeifer; Stefan H Blaas; Christian Putensen; Nils Theuerkauf; Michael Quintel; Onnen Moerer Journal: Chest Date: 2013-03 Impact factor: 9.410
Authors: Vito Fanelli; Marco V Ranieri; Jordi Mancebo; Onnen Moerer; Michael Quintel; Scott Morley; Indalecio Moran; Francisco Parrilla; Andrea Costamagna; Marco Gaudiosi; Alain Combes Journal: Crit Care Date: 2016-02-10 Impact factor: 9.097
Authors: Thomas Bein; Steffen Weber-Carstens; Anton Goldmann; Thomas Müller; Thomas Staudinger; Jörg Brederlau; Ralf Muellenbach; Rolf Dembinski; Bernhard M Graf; Marlene Wewalka; Alois Philipp; Klaus-Dieter Wernecke; Matthias Lubnow; Arthur S Slutsky Journal: Intensive Care Med Date: 2013-01-10 Impact factor: 17.440
Authors: Marianne Fitzgerald; Jonathan Millar; Bronagh Blackwood; Andrew Davies; Stephen J Brett; Daniel F McAuley; James J McNamee Journal: Crit Care Date: 2014-05-15 Impact factor: 9.097
Authors: Alain Combes; Daniel Brodie; Nadia Aissaoui; Thomas Bein; Gilles Capellier; Heidi J Dalton; Jean-Luc Diehl; Stefan Kluge; Daniel F McAuley; Matthieu Schmidt; Arthur S Slutsky; Samir Jaber Journal: Intensive Care Med Date: 2022-08-09 Impact factor: 41.787